Robshaw & Julian Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Europe ETF
VGK
|
+$4.05M |
| 2 |
SDRL
Seadrill Limited Common Stock
SDRL
|
+$1.63M |
| 3 |
Gilead Sciences
GILD
|
+$1.48M |
| 4 |
JPMorgan Chase
JPM
|
+$698K |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$2.37M |
| 2 |
SPDR Gold Trust
GLD
|
+$1.12M |
| 3 |
Nucor
NUE
|
+$770K |
| 4 |
Procter & Gamble
PG
|
+$523K |
| 5 |
RTX Corp
RTX
|
+$260K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.01% |
| 2 | Energy | 13.3% |
| 3 | Healthcare | 12.79% |
| 4 | Financials | 10.98% |
| 5 | Industrials | 10.46% |
Similar funds
Robshaw & Julian Associates's Q1 2014 Portfolio in Review
As of Q1 2014, Robshaw & Julian Associates held 43 positions worth $130M, up 7.3% from $121M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Robshaw & Julian Associates deployed $8.26M of net new capital in Q1 2014, opening 3 new positions and adding to 27 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 69,300 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was RTX Corp, an estimated $260K trimmed.
- Robshaw & Julian Associates's largest Q1 2014 buy was Vanguard FTSE Europe ETF: 69,300 shares worth $4.08M.
- Robshaw & Julian Associates added most to JPMorgan Chase in Q1 2014, an estimated $698K increase.
- Robshaw & Julian Associates's biggest Q1 2014 reduction was RTX Corp, cutting an estimated $260K.
- Robshaw & Julian Associates fully exited Teva Pharmaceuticals in Q1 2014, selling an estimated $2.37M.
- Robshaw & Julian Associates's ten largest holdings make up 42% of its $130M portfolio in Q1 2014.
- Robshaw & Julian Associates opened 3 new positions and closed 4 in Q1 2014.
- Robshaw & Julian Associates's portfolio value rose 7.3% quarter-over-quarter to $130M.
Based on Robshaw & Julian Associates's 13F filing for Q1 2014, filed 5 May 2014.